Home/Filings/4/0001140361-25-004898
4//SEC Filing

Bengtsson Carl Martin 4

Accession 0001140361-25-004898

CIK 0000009326other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 5:11 PM ET

Size

10.6 KB

Accession

0001140361-25-004898

Insider Transaction Report

Form 4
Period: 2025-02-12
Bengtsson Carl Martin
EVP & Chief Financial Officer
Transactions
  • Award

    Common Stock

    2025-02-12+2,36020,528 total
  • Award

    Stock Option

    2025-02-12+7,7007,700 total
    Exercise: $159.18Exp: 2035-02-12Common Stock (7,700 underlying)
  • Award

    Common Stock

    2025-02-13+5,43225,960 total
  • Tax Payment

    Common Stock

    2025-02-13$163.14/sh2,781$453,69223,179 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    952
Footnotes (4)
  • [F1]Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
  • [F2]Represents the vesting of performance stock units (includes 89 dividend equivalent shares) for the 2022-2024 performance period.
  • [F3]2,781 of the 5,432 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting.
  • [F4]Options vest 20% Year 1; 40% Year 2: and 40% Year 3.

Issuer

BALCHEM CORP

CIK 0000009326

Entity typeother

Related Parties

1
  • filerCIK 0001766386

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:11 PM ET
Size
10.6 KB